Gamida Cell Ltd. (GMDA) Reports Q2 EPS of $0.42

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. JBLU
4. ANT
5. META
6. SSD
7. AGYS
8. PECO
9. AMKR
10. BX

Go back to Gamida Cell Ltd. (GMDA) Reports Q2 EPS of $0.42

Gamida Cell Reports Second Quarter 2021 Financial Results and Provides Company Update

August 11, 2021 7:00 AM EDT

BLA submission for omidubicel, a potentially life-saving treatment for patients with blood cancers in need of stem cell transplant, expected in fourth quarter of 2021 Commercial readiness activities underway to support potential launch in 2022 Phase 1/2 clinical trial of GDA-201 in patients with follicular and diffuse large B-cell lymphomas expected to start by the end of the year Four new development programs announced leveraging next-generation, NAM-enabled, genetically-modified NK cells in solid tumor and hematological... More